skip to main content
Idioma:

Prevalence of COVID-19 among blood donors: The Jordan University of Science and Technology experience

Elnasser, Ziad ; Obeidat, Haneen ; Amarin, Zouhair ; Alrabadi, Nasr ; Jaradat, Abdullah ; Alomarat, Du'a ; BaniSalem, Mo'ath ; Almomani, Randa

Medicine (Baltimore), 2021-10, Vol.100 (41), p.e27537-e27537 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
  • Título:
    Prevalence of COVID-19 among blood donors: The Jordan University of Science and Technology experience
  • Autor: Elnasser, Ziad ; Obeidat, Haneen ; Amarin, Zouhair ; Alrabadi, Nasr ; Jaradat, Abdullah ; Alomarat, Du'a ; BaniSalem, Mo'ath ; Almomani, Randa
  • Assuntos: Adult ; Blood Donors - statistics & numerical data ; Blood Group Antigens - immunology ; COVID-19 - epidemiology ; Female ; Humans ; Jordan - epidemiology ; Male ; Observational Study ; Pandemics ; Prevalence ; Prospective Studies ; SARS-CoV-2
  • É parte de: Medicine (Baltimore), 2021-10, Vol.100 (41), p.e27537-e27537
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    ObjectType-Undefined-3
  • Descrição: The corona virus disease-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, had health and economic results that profoundly affected communities worldwide. Investigating the seroprevalence of SARS-Cov-2 in blood donors is of a significant clinical and scientific value as it adds to knowledge about local herd immunity levels.To study the prevalence of SARS-Cov-2 infection among blood donors at a tertiary referral hospital in the north of Jordan.This is a prospective study that included all blood donors between September 2020 and March 2021. Donors' IgG antibodies were qualitatively immunoassayed to determine the antibody status against SARS-CoV-2. The Elecsys Anti-SARS-CoV-2 technique was utilized.One thousand samples were tested by total antibody against SARS-CoV-2. The median age was 29 years, 96.7% were males. The seroprevalence was 14.5%, and 80% of the positive participants did not report previous COVID-19 infection. The seroprevalence of COVID-19 antibodies was less among smokers and those with an O blood group and higher among donors with an AB blood group.The prevalence of COVID-19 among healthy young blood donors at a tertiary teaching health facility in the north of Jordan was 14.5%. Smokers and those with an O blood group were less likely to be seropositive, as opposed to donors with an AB blood group.
  • Editor: United States: Lippincott Williams & Wilkins
  • Idioma: Inglês
Links
Voltar para lista de resultados
Resultado  1 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.